Investigating Potential Claims – Boston Therapeutics
Are you concerned about your investment in Boston Therapeutics? If so, the securities attorneys at The White Law Group may be able to help you by filing a FINRA Arbitration claim against the brokerage firm that sold you the investment.
According to Bloomberg, Boston Therapeutics, Inc., is a pre-clinical and clinical-stage pharmaceutical company. The company reportedly focuses on the development, manufacture, and commercialization of carbohydrate-based therapeutic drugs and dietary supplements in the United States.
The company was formerly known as Avanyx Therapeutics, Inc. and changed its name to Boston Therapeutics, Inc. in November 2010. Boston Therapeutics, Inc. was founded in 2009 and is headquartered in Lawrence, Massachusetts.
According to SEC filings, Boston Therapeutics Inc. filed a Form D to raise capital from investors in Manchester, NH in 2013. The total offering amount is $8,000,000.
Investments such as these are typically sold by brokerage firms in exchange for a large up front commission. High fees can range from 7-10%, as well as additional “due diligence fees” that can range from 1-3%.
The problem with private placement investments such as Boston Therapeutics is that they typically involve a high degree of risk. They are also often sold as unregistered securities which lack the same regulatory oversight as more traditional investment products like stocks or bonds.
Free Consultation with a Securities Attorney
The White Law Group is investigating the liability that FINRA registered brokerage firms may have for unsuitably recommending high-risk private placements, like Boston Therapeutics Inc., to investors.
Despite the risks of investing in private placements, brokerage firms continue to push this type of investment because of the high commissions associated with their sale and creation.
If you have concerns regarding your investment in Boston Therapeutics Inc. and would like to speak with a securities attorney about your options, please call The White Law Group at 888-637-5510.
The White Law Group, LLC is a national securities fraud, securities arbitration, investor protection, and securities regulation/compliance law firm with offices in Chicago, Illinois and Franklin, Tennessee.
For more information on The White Law Group and its representation of investors in FINRA arbitration claims, visithttps://whitesecuritieslaw.com.
Tags: Avanyx Therapeutics Boston Therapeutics, Avanyx Therapeutics investigation, Avanyx Therapeutics lawsuit, Avanyx Therapeutics losses, Boston Therapeutics Inc. complaints, Boston Therapeutics Inc. help, Boston Therapeutics Inc. high commissions, Boston Therapeutics Inc. information, Boston Therapeutics Inc. investigation, Boston Therapeutics Inc. investment, Boston Therapeutics Inc. investment losses, Boston Therapeutics Inc. investor relations, Boston Therapeutics Inc. investors, Boston Therapeutics Inc. losses, Boston Therapeutics Inc. ppm, Boston Therapeutics Inc. private placement, Boston Therapeutics Inc. prospectus, Boston Therapeutics Inc. real estate, Boston Therapeutics Inc. recovery options, Boston Therapeutics Inc. risk, Boston Therapeutics Inc. stock information, Boston Therapeutics Inc. update Last modified: May 10, 2018